[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356875-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-356875-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","potential-role-of-breast-mri-to-identify-patients-with-high-risk-lesions-who-might-avoid-surgery-a-systematic-review-and-meta-analysis","Potential role of breast MRI to identify patients with high-risk lesions who might avoid surgery - a systematic review and meta-analysis","","This systematic review and meta-analysis evaluates the added value of contrast-enhanced breast MRI (CEMRI) for ruling out malignancy in patients with high-risk (B3) lesions diagnosed at image-guided biopsy. Predefined criteria were used to extract true/false positives and negatives across eligible English-language studies through August 2024. Pooled results show high sensitivity with moderate specificity, few missed malignancies limited to small low-grade DCIS, and a negative MRI post-test threshold aligned to downgrading BI-RADS 4 to 3. Findings support safe non-surgical strategies.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/potential-role-of-breast-mri-to-identify-patients-with-high-risk-lesions-who-might-avoid-surgery-a-systematic-review-and-meta-analysis/356875/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/potential-role-of-breast-mri-to-identify-patients-with-high-risk-lesions-who-might-avoid-surgery-a-systematic-review-and-meta-analysis/356875.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical question does this systematic review address?","Question",{"text":63,"@type":64},"It investigates whether contrast-enhanced breast MRI can rule out malignancy in patients with high-risk (B3) lesions found on image-guided biopsy, supporting more tailored decisions and fewer unnecessary surgeries.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was diagnostic performance of CE-MRI evaluated?",{"text":68,"@type":64},"Eligible English-language studies through August 2024 were included, with extracted true/false positives and negatives. Sensitivity, specificity, and likelihood ratios were calculated using a bivariate random-effects model, and heterogeneity was assessed with I² and meta-regression.",{"name":70,"@type":61,"acceptedAnswer":71},"What types of cancers were missed despite a negative CE-MRI?",{"text":72,"@type":64},"Only 6/493 malignancies were missed, and all were small, low-grade ductal carcinoma in situ (DCIS).",{"name":74,"@type":61,"acceptedAnswer":75},"At what pretest probability can malignancy be reliably ruled out?",{"text":76,"@type":64},"Fagan nomograms indicate CE-MRI could rule out malignancy when pretest probability is up to 13.1%, aligning with the negative MRI threshold used to downgrade BI-RADS 4 to 3.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},356875,1790214722,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Vatteroni et al. European Radiology (2026) 36:4434–4444  \n[https://doi.org/10.1007/s00330-025-12291-9](https://doi.org/10.1007/s00330-025-12291-9)  \nBREAST Open Access  \nPotential role of breast MRI to identify patients with high-risk lesions who might avoid surgery: a systematic review and meta-analysis  \nGiulia Vatteroni 1, Nina Pirringer-Pötsch2, Paola Clauser2 and Pascal A. T. Baltzer2*   \nAbstract  \nObjective This systematic review and meta-analysis investigate the added value of contrast-enhanced breast MRI (CEMRI) to rule out malignancy in patients with high-risk (B3) lesions diagnosed at image-guided biopsy.  \nMaterials and methods A systematic review and meta-analysis were performed using predeﬁned criteria. Eligible Englishlanguage articles published until August 2024 focused on CE-MRI in high-risk lesions. Two reviewers extracted data on true positives (TP), false positives (FP), true negatives (TN), and false negatives (FN) . Sensitivity, speciﬁcity, negative and positive likelihood ratios were calculated using a bivariate random-effects model. Fagan nomograms identiﬁed the maximum pretest probability at which post-test probabilities of a negative MRI matched the 2% malignancy threshold used for downgrading BI-RADS 4 to 3 . I² statistics and meta-regression explored heterogeneity. p-values \u003C 0 .05 were considered signiﬁcant. Results Seven studies comprising 479 patients with 493 high-risk lesions undergoing CE-MRI were included. The average breast cancer prevalence was 17%(88/493) . Pooled sensitivity was 91 .3%(95% CI: 82 .8–95.8%) and pooled speciﬁcity was 68.8%(95% CI: 50.3–82.8%). Only 6/493 malignancies were missed by CE-MRI; all were small low-grade ductal carcinoma in situ (DCIS) . Fagan nomograms indicated that CE-MRI could rule out malignancy in lesions with pretest probabilities up to 13 . 1% .  \nConclusions CE-MRI in assessing high-risk lesions may help identify patients who can safely avoid surgery, potentially reducing morbidity, anxiety, and healthcare resource use. Malignancy can be reliably ruled out in lesions with pretest probabilities ≤ 13. 1%, although prospective studies are suggested for conﬁrmation.  \nKey Points  \nQuestion Can contrast-enhanced breast MRI help to rule out malignancy in patients with high-risk lesions at imaging-guided biopsy, thereby supporting more tailored decisions and potentially reducing unnecessary surgical excisions?  \nFindings Contrast-enhanced breast MRI may reduce unnecessary surgical or vacuum excisions in high-risk (B3) lesions. Missed cancers were limited to small low-grade DCIS.  \nClinical relevance Contrast-enhanced breast MRI may support the identiﬁcation of patients with high-risk lesions who could potentially avoid surgery. This non-invasive approach has the potential to reduce overtreatment, healthcare costs, and patient anxiety, while maintaining a high negative predictive value.  \n*Correspondence: Pascal A. T. Baltzer  \n[pascal.baltzer@meduniwien.ac.at](pascal.baltzer@meduniwien.ac.at)  \n1Department of Biomedical Sciences, Humanitas University, Milan, Italy 2Department of Biomedical Imaging and Image-guided Treatment, High ﬁeld Magnetic Resonance Center (HFMRC), Medical University of Vienna, Vienna, Austria  \n© The Author(s) 2026 . Open Access This article is licensed under a Creative Commons Attribution 4 . 0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission dir","cbCaidH4Cyjk5K3t","https://ap.wps.com/l/cbCaidH4Cyjk5K3t","pdf",1420546,11,"English","# Abstract\n## Objective\n## Materials and methods\n## Results\n## Conclusions\n# Key points\n## Question\n## Findings\n## Clinical relevance\n# Introduction","[{\"question\":\"What clinical question does this systematic review address?\",\"answer\":\"It investigates whether contrast-enhanced breast MRI can rule out malignancy in patients with high-risk (B3) lesions found on image-guided biopsy, supporting more tailored decisions and fewer unnecessary surgeries.\"},{\"question\":\"How was diagnostic performance of CE-MRI evaluated?\",\"answer\":\"Eligible English-language studies through August 2024 were included, with extracted true/false positives and negatives. Sensitivity, specificity, and likelihood ratios were calculated using a bivariate random-effects model, and heterogeneity was assessed with I² and meta-regression.\"},{\"question\":\"What types of cancers were missed despite a negative CE-MRI?\",\"answer\":\"Only 6/493 malignancies were missed, and all were small, low-grade ductal carcinoma in situ (DCIS).\"},{\"question\":\"At what pretest probability can malignancy be reliably ruled out?\",\"answer\":\"Fagan nomograms indicate CE-MRI could rule out malignancy when pretest probability is up to 13.1%, aligning with the negative MRI threshold used to downgrade BI-RADS 4 to 3.\"}]","Potential role of breast MRI to identify patients with high-risk lesions who might avoid surgery - a systematic review and meta-analysis | PDF",1790127860,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e0e8003fbc9be5c7e71727da1759e96.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59baa4fea049cd8b89490475b79e9cb5.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2eaa2710b631ce792b04407b1e97bba0.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f52266463c84354065ae0f875688f037.webp",980,1301]